StevenA. Rosenberg

447 total citations
7 papers, 367 citations indexed

About

StevenA. Rosenberg is a scholar working on Immunology, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, StevenA. Rosenberg has authored 7 papers receiving a total of 367 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 5 papers in Oncology and 2 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in StevenA. Rosenberg's work include Immune Cell Function and Interaction (4 papers), Immunotherapy and Immune Responses (3 papers) and CAR-T cell therapy research (3 papers). StevenA. Rosenberg is often cited by papers focused on Immune Cell Function and Interaction (4 papers), Immunotherapy and Immune Responses (3 papers) and CAR-T cell therapy research (3 papers). StevenA. Rosenberg collaborates with scholars based in United States and Australia. StevenA. Rosenberg's co-authors include S. Schwarz, Amitabha Mazumder, Maury Rosenstein, Paul J. Spiess, Robert Wesley, Joe McIntosh, René Lafrenière, Eitan Shiloni, Alan Kawarai Lefor and Anthony L. Asher and has published in prestigious journals such as Cancer Immunology Immunotherapy and Springer Seminars in Immunopathology.

In The Last Decade

StevenA. Rosenberg

7 papers receiving 344 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
StevenA. Rosenberg United States 6 255 146 95 30 30 7 367
Giuseppe Consogno Italy 10 295 1.2× 149 1.0× 108 1.1× 33 1.1× 18 0.6× 14 373
W Tietz Germany 6 352 1.4× 113 0.8× 67 0.7× 33 1.1× 39 1.3× 12 492
Giuseppe Tortolina Italy 8 298 1.2× 109 0.7× 134 1.4× 16 0.5× 25 0.8× 9 416
Belinda Baltus Netherlands 9 185 0.7× 113 0.8× 95 1.0× 32 1.1× 22 0.7× 11 409
Hedda H. van Ravenswaay Claasen Netherlands 7 180 0.7× 154 1.1× 127 1.3× 31 1.0× 37 1.2× 10 401
Jessica Cantrell United States 8 291 1.1× 160 1.1× 78 0.8× 10 0.3× 18 0.6× 10 396
Carmela Rozera Italy 7 179 0.7× 116 0.8× 106 1.1× 14 0.5× 36 1.2× 9 305
Anne M. King United States 11 260 1.0× 107 0.7× 130 1.4× 29 1.0× 20 0.7× 14 480
David L. Pflugh United States 8 281 1.1× 90 0.6× 222 2.3× 31 1.0× 49 1.6× 9 457
Ioannis Tassiulas United States 9 409 1.6× 149 1.0× 113 1.2× 40 1.3× 16 0.5× 17 564

Countries citing papers authored by StevenA. Rosenberg

Since Specialization
Citations

This map shows the geographic impact of StevenA. Rosenberg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by StevenA. Rosenberg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites StevenA. Rosenberg more than expected).

Fields of papers citing papers by StevenA. Rosenberg

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by StevenA. Rosenberg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by StevenA. Rosenberg. The network helps show where StevenA. Rosenberg may publish in the future.

Co-authorship network of co-authors of StevenA. Rosenberg

This figure shows the co-authorship network connecting the top 25 collaborators of StevenA. Rosenberg. A scholar is included among the top collaborators of StevenA. Rosenberg based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with StevenA. Rosenberg. StevenA. Rosenberg is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Rosenberg, StevenA., et al.. (1989). Heterogeneous lymphokine-activated killer cell precursor populations. Cancer Immunology Immunotherapy. 29(3). 14 indexed citations
2.
Schwarz, S., et al.. (1988). Transforming growth factor-beta inhibits the in vitro generation of lymphokine-activated killer cells and cytotoxic T cells. Cancer Immunology Immunotherapy. 26(2). 95–100. 132 indexed citations
3.
Asher, Anthony L., Joe McIntosh, René Lafrenière, et al.. (1988). Antitumor effect of recombinant tumor necrosis factor-? against murine sarcomas at visceral sites: tumor size influences the response to therapy. Cancer Immunology Immunotherapy. 26(3). 202–8. 32 indexed citations
4.
Rosenberg, StevenA., et al.. (1986). The adoptive immunotherapy of cancer using lymphokine activated killer cells and recombinant interleukin-2. Springer Seminars in Immunopathology. 9(1). 51–71. 121 indexed citations
5.
Mazumder, Amitabha, et al.. (1983). Lysis of fresh human solid tumor cells by autologous lymphocytes activated in vitro by allosensitization. Cancer Immunology Immunotherapy. 15(1). 1–10. 40 indexed citations
6.
Rosenstein, Maury, et al.. (1982). Adoptive chemoimmunotherapy of a syngeneic murine lymphoma with long-term lymphoid cell lines expanded in T cell growth factor. Cancer Immunology Immunotherapy. 13(1). 5–13. 27 indexed citations
7.
Rosenberg, StevenA., et al.. (1981). Serologic analysis of human tumor antigens. Cancer Immunology Immunotherapy. 11(4). 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026